![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Abstracts Accepted for Publication - AB0693 Patients with chronic inflammatory arthropathies treated with golimumab achieve a higher serum level of drug if used as the first or second biological drug
Rosas, J, Marco-Mingot, M, Senabre-Gallego, JM, Llinares-Tello, F, Pons, A, Barber, X, Santos-Soler, G, Salas, E, Cano, C, Lorente, M, Sanchís-Selfa, M, Molina, J, García-Carrasco, MLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.4308
File:
PDF, 207 KB
english